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of Plasma ACTH Through Corticotropin-Releasing Factor 
in a Patient with Central Cushing's Disease due 
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Summary. Three uncommon findings were ob- 
served in a case of Cushing's disease due to mac- 
roadenoma: no suppression ofplasma ACTH dur- 
ing an 8-rag dexamethasone test, a negative corti- 
cotropin-releasing factor test, and a normal X-ray 
of the sella turcica. Despite these findings, the diag- 
nosis of pituitary was confirmed Cushing's syn- 
drome by computerized tomography and a trans- 
phenoidal operation. 
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Verification of hypercortisolism and differentia- 
tion of central, peripheral, and paraneoplastic CS 
is usually achieved by means of 2-mg and 8-mg 
dexamethasone tests, together with determination 
of plasma ACTH. The latter may have to be sam- 
pled selectively at different sites, if ectopic ACTH 
production is suspected [8]. 
The positive response in the CRF test has be- 
come an important alternative to the lysin-vaso- 
pressin test [6, 7] in central CS. However, our case 
illustrates that the various function tests did not 
help in the diagnosis of a case of pituitary CD 
with macroadenoma, which was diagnosed only 
by CT. 
Case Details 
A female patient, 44 years of age, had had an ap- 
pendectomy in 1956 and a thyroid adenoma surgi- 
Abbreviations: CRF=corticotropin releasing factor; CD= 
Cushing's disease; CS=Cushing's syndrome; CT=computer- 
ized tomography; GH = growth hormone; FSH = follicle-stim- 
ulating hormone; I.H = tuteinizing hormone; LH-RH = lutein- 
izing hormone releasing hormone 
cally removed in 1961. Since 1981, she had gained 
weight, especially in the cervical and facial regions, 
and since 1982 had had irregular menstruation. 
When examined, she was 165 cm tall and weighed 
65 kg. Distinct CS stigmata were evident (" moon" 
face, "buffalo" hump, truncal obesity, and hirsut- 
ism), and her blood pressure was 200/100 mm Hg. 
Laboratory findings were normal, except for leuco- 
cytosis with relative lymphopenia and a blood sedi- 
mentation rate of 46/86. The results of the hor- 
monal function tests are shown in Table 1. 
All other tests of pituitary function, such as 
LH, FSH, prolactin (even under stimulation), as 
well as testosterone and thyroid hormone determi- 
nations, showed no pathological results. A CRF 
test (synthetic ovine CRF from Bachem Inc., Bu- 
bendorf, Switzerland; prepared as described pre- 
Table 1. Preoperative hormonal investigations 
Urinary 17-Ketosteroids 17-Hydroxycorticoids 
excretion/24 h 50.1 mg 20.0 mg 
Normal ranges 
Plasma ACTH Serum cortisol 
at 8 a.m. 8 a.m. 4 p.m. 
139 pg/ml 255 260 ng/ml 








at 8 a.m. 
201 ng/ml 
282 ng/mt 
Normal: < 20 ng/ml 
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Fig. i. ACTH (o) and cortisoI (o) responses to I00 gg CRF 
before (oo-- -cD) and after (co---oD) transphenoidal adenomec- 
tomy because of Cushing's disease. (For details, see text) 
viously [2]) produced no stimulation of the 
ACTH 1 and cortisol values (Fig. 1). 
Radiological Examinations 
Normal findings were observed on conventional 
X-ray films of thorax and cranium, tomograms of 
hilus and sella turciea, and pyelograms. An ab- 
dominal CT showed: normal kidneys and pancre- 
as; adrenal glands of regular outline that were 
large but still within the normal range. A cranial 
CT showed a large, partially cystic, pituitary ad- 
enoma infiltrating the sphenoidal sinus. 
No defects were found in the visual fields. 
Progress 
The pituitary adenoma was removed selectively, 
and probably subtotally by the transnasal route. 
A large tumour was found, which had developed 
from a mostly intact sella in the subarachnoidal 
space and the sphenoidal sinus. Histologically, the 
tumour was an undifferentiated mucoid cell-ad- 
enoma showing signs of infiltration of the bone 
and subarachnoidal space. Immunostaining re- 
vealed 20% ACTH-positive cells. After adenomec- 
tomy, plasma ACTH and cortisol evels slowly de- 
creased, and the symptoms of CS disappeared. 
Two months later, the morning cortisol level was 
89 ng/ml, while the ACTH level was still sfightly 
elevated (120 pg/ml). The patient now suffered 
from neuralgia, tiredness, and morning depression. 
Pituitary functions were controlled with an LH- 
1 The determination f ACTH by radioimmunoassay [5] by 
Dr. Klingler, Inst. ffir Biochem. Endokrinol., Med. ttoch- 
schule Liibeck, is gratefully acknowledged 
RH ACTH-stimulation test, with normal values 
for cortisol, LH, FSH, prolactin, and GH. 
The CRF test now resulted in normal stimula- 
tion of ACTH and cortisol (Fig. 1). Because of 
persistently increased ACTH levels, the sella region 
was prophylactically irradiated (60 Gy). 
Discussion 
This case clearly illustrates ome difficulties in the 
diagnosis of hypercortisolism. We confirm that the 
failure of 8-mg dexamethasone to suppress ACTH 
does not exclude pituitary CS [I] in all cases. 
The negative CRF test before adenomectomy 
remains unexplained, as there is usually a signifi- 
cant increase of ACTH and cortisol within the first 
hour of the test in patients with central CS [2, 
6, 7, 9]. Improper application of CRF is an unlike- 
ly explanation, since the patient showed the usual 
symptoms of flush and heat waves during both 
tests [7, 9]. 
The case history makes a paraneoplastic a tivi- 
ty improbable. A pituitary carcinoma producing 
ACTH is not supported by the histological findings 
and by the only slightly increased ACTH levels; 
the infiltrative character of the adenoma nd the 
cell type is also noted. 
The size of the tumour esponses in the lysin- 
vasopressin and CRF tests far exceeded the normal 
stimulation values reported for large ACTH-pro- 
ducing adenomas [3, 6]. The patient's tumour pro- 
duced only slightly elevated ACTH levels, in spite 
of its size, and showed no reaction to CRF. 
In addition, we hypothesise that the CRF-sen- 
sitive ACTH-producing cells of the normal pitui- 
tary tissue became suppressed, preoperatively, 
under the influence of the tumour. The postopera- 
tive stimulation values may represent normal pitui- 
tary. However, this explanation is in contrast with 
the finding that the ACTH secretion of the para- 
adenomatous pituitary is regularly suppressed 
after adenomectomy in CD [4]. More likely, the 
small remainder of the adenoma was changing in 
receptor sensitivity to CRF after reduction of the 
cortisol excess. Finally, this case history indicates 
that despite finding a normal sella structure in a 
conventional X-ray picture, there may still be a 
macroadenoma of the pituitary. It is therefore ad- 
visable to include a CT of the pituitary region in 
the primary program. 
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Note Added in Proof 
The problem that the CRF test does not produce ACTH and 
cortisol elevations in all patients with Cushing's disease has 
previously been described by Pieters et al. (Pieters GFFM, Her- 
mus ARMM, Smals AGH, Bartelink AKM, Benraad TH J, 
Kloppenborg PWC (1983). Responsiveness of the Hypophyse- 
al-Adrenocortical Axis to Corticotropin - Releasing Factor in 
Pittfitary-Dependent Cushing's Disease. J Clin Endocrinol 
Metab 57 : 513-516) 
